Revvity Inc (RVTY) is a company that specializes in advanced technical analysis tools and indicators for stock trading. They provide a comprehensive suite of indicators that can help traders make informed decisions and maximize their profits. In this article, we will take a closer look at some of the key technical indicators provided by Revvity Inc.

One of the most commonly used technical indicators is the Relative Strength Index (RSI). This indicator measures the speed and change of price movements and helps traders identify overbought or oversold conditions. The RSI ranges from 0 to 100, with values above 70 indicating overbought conditions and values below 30 indicating oversold conditions.

Revvity  (RVTY) Technical Analysis

Learn about Revvity Inc (RVTY) through technical analysis indicators such as RSI, ADX, and MACD. Understand the stock's ROC, STOCHRSI, and WILLR values. Get a comprehensive rating based on technical analysis.

Revvity Inc (RVTY) - Technical Analysis: RSI, ADX, MACD

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Revvity 

NYSE

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	52.06	Neutral	97.0%
auto_graphMACD	0.67	Neutral	3.8%
auto_graphCCI	21.73	Neutral	39.5%
auto_graphADX	7.90	Neutral	-48.1%
auto_graphATR	6.97	Buy	-
auto_graphWILLR	-52.85	Neutral	21.9%
auto_graphROC	2.71	Neutral	14.8%
auto_graphSTOCHRSI	95.34	Sell	16.8%

Buy	1	-87.50%
Hold	6	-25.00%
Sell	1	-87.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Revvity (RVTY) Technical Analysis

Keep an eye on Revvity

Frequently Asked Questions

What are the technical signals for Revvity (RVTY) stock based on the last 30 days?

Take Your Investments to a Whole New Level